Factors
|
Univariate
|
Multivariate
|
---|
HR
|
95% CI
|
P
|
HR
|
95% CI
|
P
|
---|
Without BD induction
|
4.730
|
1.003-22.307
|
0.050
|
4.359
|
0.913-20.823
|
0.065
|
Urine protein >3.5 g/24 hour
|
1.2
|
0.310-4.647
|
0.792
| | | |
Cardiac stage III
|
4.118
|
1.138-14.899
|
0.031
|
1.272
|
0.276-5.864
|
0.758
|
Baseline BNP >170 ng/L
|
2.837
|
0.814-9.892
|
0.104
| | | |
Troponin-I >0.03
|
6.494
|
1.673-25.213
|
0.007
|
6.138
|
1.559-24.170
|
0.009
|
The use of MEL 140
|
3.445
|
0.730-16.255
|
0.118
| | | |
- BD, bortezomib in combination wity dexamethasone; BNP, brain natriuretic peptide; CI, confidence interval; HR, hazard ratio; MEL, melphalan.